Photodynamic therapy of atherosclerosis using YAG-OPO laser and Porfimer sodium, and comparison with using argon-dye laser.
We performed photodynamic therapy (PDT) using the Yttrium Aluminium Garnet-Optical Parametric Oscillated (YAG-OPO) laser in cases of atherosclerosis, and examined its efficacy in vivo. We also performed PDT using an Argon-dye (Ar-dye) laser with the same output, and compared the efficacies. Following balloon denudation injury of the thoracoabdominal aorta, rabbits were raised on a cholesterol diet for 16 weeks, producing atheroma in that region. At 24 h following the administration of Photofrin 5 mg/kg, PDT was performed, and animals were sacrificed at 1 day, 1 week, and 2 weeks following the procedure to examine its efficacy. This was compared with the efficacy of PDT using the Ar-dye laser. Following PDT using a YAG-OPO laser, an increase in the vessel lumen was seen due to reduction of the hypertrophic intima and media, without the appearance of inflammatory cells. This result was seen more strongly in PDT using the pulse wave YAG-OPO laser than with the continuous wave Ar-dye laser, affecting not just the intima but also the media. These data demonstrated that PDT can effectively regress atherosclerotic lesions.
Amemiya
T
T
Second Department of Internal Medicine, Tokyo Medical University, Japan.
Nakajima
H
H
Katoh
T
T
Rakue
H
H
Miyagi
M
M
Ibukiyama
C
C
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D004036:Diet, Atherogenic; D017323:Dihematoporphyrin Ether / Q000627:therapeutic use*; D007834:Lasers; D010778:Photochemotherapy / Q000295:instrumentation; D011817:Rabbits
D000970:Antineoplastic Agents; D002791:Cholesterol, Dietary; D017323:Dihematoporphyrin Ether